AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle

Journal of Physiology

Volumn 591, Issue 20, 2013, Pages 5207-5220

  Brandauer, Josef ^a,b,c   Vienberg, Sara G ^a   Andersen, Marianne A ^a   Ringholm, Stine ^d   Risis, Steve ^a   Larsen, Per S ^a   Kristensen, Jonas M ^d   Frøsig, Christian ^d   Leick, Lotte ^d   Fentz, Joachim ^d   Jørgensen, Sebastian ^d   Kiens, Bente ^d   Wojtaszewski, Jørgen F P ^d   Richter, Erik A ^d   Zierath, Juleen R ^a,e   Goodyear, Laurie J ^c   Pilegaard, Henriette ^d   Treebak, Jonas T ^a  

^a Capital Region   (Denmark)

^b GETTYSBURG COLLEGE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ENERGY; ENDURANCE TRAINING; EXTENSOR MUSCLE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; KNEE FUNCTION; LEG EXERCISE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SUBUNIT; REGULATORY MECHANISM; SKELETAL MUSCLE; WILD TYPE;

ADENYLATE KINASE; ADULT; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; EXERCISE; HEK293 CELLS; HUMANS; MALE; MICE; MUSCLE, SKELETAL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHYSICAL EXERTION; RIBONUCLEOTIDES;

EID: 84885431554     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.259515     Document Type: Article

References (53)

1. Andersen P, Adams RP, Sjøgaard G, Thorboe A & Saltin B (1985). Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol 59, 1647-1653.
2. Bailey CJ & Puah JA (1986). Effect of metformin on glucose metabolism in mouse soleus muscle. Diabete Metab 12, 212-218.
3. Barnes BR, Glund S, Long YC, Hjälm G, Andersson L & Zierath JR (2005). 5′-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J 19, 773-779.
4. Barnes BR, Marklund S, Steiler TL, Walter M, Hjälm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR & Andersson L (2004). The 5′-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279, 38441-38447.
5. Barré L, Richardson C, Hirshman MF, Brozinick J, Fiering S, Kemp BE, Goodyear LJ & Witters LA (2007). Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. Am J Physiol Endocrinol Metab 292, E802-E811.
6. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M & Sinclair DA (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277, 45099-45107.
7. Bouras T, Fu M, Sauve AA, Wang F, Quong AA, Perkins ND, Hay RT, Gu W & Pestell RG (2005). SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem 280, 10264-10276.
8. Bumpus NN & Johnson EF (2011). 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5′-monophosphate-dependent and AMP-activated protein kinase-independent. J Pharmacol Exp Ther 339, 886-895.
9. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P & Auwerx J (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060.
10. Cantó C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR & Auwerx J (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11, 213-219.
11. Caton PW, Kieswich J, Yaqoob MM, Holness MJ & Sugden MC (2011). Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice. Diabetes Obes Metab 13, 1097-1104.
12. Corton JM, Gillespie JG, Hawley SA & Hardie DG (1995). 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells Eur J Biochem 229, 558-565.
13. Costford SR, Bajpeyi S, Pasarica M, Albarado DC, Thomas SC, Xie H, Church TS, Jubrias SA, Conley KE & Smith SR (2010). Skeletal muscle NAMPT is induced by exercise in humans. Am J Physiol Endocrinol Metab 298, E117-E126.
14. Cusi K & Defronzo RA (1998). Metformin: a review of its metabolic effects. Diabetes Reviews 6, 89-131.
15. Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K & Auwerx J (2007). Sirtuins: the "magnificent seven", function, metabolism and longevity. Ann Med 39, 335-345.
16. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
17. Egan B & Zierath JR (2013). Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 17, 162-184.
18. Frøsig C, Jørgensen SB, Hardie DG, Richter EA & Wojtaszewski JFP (2004). 5′-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 286, E411-E417.
19. Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, Holland WL, Summers SA, Hirshman MF & Goodyear LJ (2008). Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 57, 2958-2966.
20. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA & Sartorelli V (2008). Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14, 661-673.
21. Garten A, Petzold S, Körner A, Imai S-I & Kiess W (2009). Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 20, 130-138.
22. Holmes BF, Kurth-Kraczek EJ & Winder WW (1999). Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87, 1990-1995.
23. Jäger S, Handschin C, St-Pierre J & Spiegelman BM (2007). AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104, 12017-12022.
24. Jørgensen SB, Richter EA & Wojtaszewski JFP (2006). Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol 574, 17-31.
25. Jørgensen SB, Treebak JT, Viollet B, Schjerling P, Vaulont S, Wojtaszewski JFP & Richter EA (2007). Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab 292, E331-E339.
26. Jørgensen SB, Wojtaszewski JFP, Viollet B, Andreelli F, Birk JB, Hellsten Y, Schjerling P, Vaulont S, Neufer PD, Richter EA & Pilegaard H (2005). Effects of α-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J 19, 1146-1148.
27. Koh H-J, Arnolds DE, Fujii N, Tran TT, Rogers MJ, Jessen N, Li Y, Liew CW, Ho RC, Hirshman MF, Kulkarni RN, Kahn CR & Goodyear LJ (2006). Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26, 8217-8227.
28. Koh H-J, Brandauer J & Goodyear LJ (2008). LKB1 and AMPK and the regulation of skeletal muscle metabolism. Curr Opin Clin Nutr Metab Care 11, 227-232.
29. Kohlstedt K, Trouvain C, Boettger T, Shi L, Fisslthaler B & Fleming I (2013). AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res 112, 1150-1158.
30. Kristensen JM, Larsen S, Helge JW, Dela F & Wojtaszewski JFP (2013). Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice. PLoS ONE 8, e53533.
31. Leick L, Fentz J, Biensø RS, Knudsen JG, Jeppesen J, Kiens B, Wojtaszewski JFP & Pilegaard H (2010). PGC-1α is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am J Physiol Endocrinol Metab 299, E456-E465.
32. Leick L, Wojtaszewski JFP, Johansen ST, Kiilerich K, Comes G, Hellsten Y, Hidalgo J & Pilegaard H (2008). PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab 294, E463-E474.
33. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jäger S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D & Spiegelman BM. (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119, 121-135.
34. Lin S-J, Defossez PA & Guarente L (2000). Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126-2128.
35. Lin S-J, Kaeberlein M, Andalis AA, Sturtz LA, Defossez P-A, Culotta VC, Fink GR & Guarente L (2002). Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 418, 344-348.
36. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L & Gu W (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148.
37. McGee SL, Howlett KF, Starkie RL, Cameron-Smith D, Kemp BE & Hargreaves M (2003). Exercise increases nuclear AMPK alpha2 in human skeletal muscle. Diabetes 52, 926-928.
38. Mu J, Brozinick JT Jr, Valladares O, Bucan M & Birnbaum MJ (2001). A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7, 1085-1094.
39. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A & Goodyear LJ (2002). Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081.
40. Nemoto S, Fergusson MM & Finkel T (2005). SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 280, 16456-16460.
41. Philp A, Chen A, Lan D, Meyer GA, Murphy AN, Knapp AE, Olfert IM, McCurdy CE, Marcotte GR, Hogan MC, Baar K & Schenk S (2011). Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) deacetylation following endurance exercise. J Biol Chem 286, 30561-30570.
42. Puigserver P, Wu Z, Park CW, Graves R, Wright M & Spiegelman BM (1998). A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839.
43. Rechsteiner M, Hillyard D & Olivera BM (1976). Magnitude and significance of NAD turnover in human cell line D98/AH2. Nature 259, 695-696.
44. Revollo JR, Grimm AA & Imai S (2004). The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279, 50754-50763.
45. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM & Puigserver P (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118.
46. (2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions. J Physiol 587, 1547-1563.
47. Sabina RL, Kernstine KH, Boyd RL, Holmes EW & Swain JL (1982). Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle. Effects on purine nucleotide synthesis. J Biol Chem 257, 10178-10183.
48. Treebak JT, Birk JB, Hansen BF, Olsen GS & Wojtaszewski JFP (2009). A-769662 activates AMPK beta1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. Am J Physiol Cell Physiol 297, C1041-C1052.
49. Turban S, Stretton C, Drouin O, Green CJ, Watson ML, Gray A, Ross F, Lantier L, Viollet B, Hardie DG, Marette A & Hundal HS (2012). Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. J Biol Chem 287, 20088-20099.
50. Viollet B, Andreelli F, Jørgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R & Vaulont S (2003). The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111, 91-98.
51. Wang P, Zhang R-Y, Song J, Guan Y-F, Xu T-Y, Du H, Viollet B & Miao C-Y (2012). Loss of AMP-activated protein kinase-α2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle. Diabetes 61, 1051-1061.
52. Wojtaszewski JFP, Birk JB, Frøsig C, Holten M, Pilegaard H & Dela F (2005). 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 564, 563-573.
53. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ & Moller DE (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167-1174.